Table 2.
Anticancer (LC50 in µg/mL) of compounds from 1–6 and their selectivity index (SI).
Compounds | Cytotoxicty (LC50 in µg/mL) | Selectivity Index* | ||||||
HeLa cells | Vero cells | HeLa cells |
V. cholerae SG24 (1) |
V. cholerae CO6 |
V. cholerae NB2 |
V. cholerae PC2 |
S. flexneri SDINT |
|
1 | 6.33 ± 0.66a | 124.72 ± 1.27a | 19.70 | 15.59 | 7.79 | 3.89 | 3.89 | 7.79 |
2 | 6.74 ± 0.27a | 158.24 ± 2.86b | 23.47 | 39.56 | 4.94 | 9.89 | 19.78 | 9.89 |
3 | 8.13 ± 0.18b | 233.26 ± 3.73c | 28.69 | 466.52 | 14.57 | 29.15 | 466.52 | 29.15 |
4 | 9.21 ± 0.79b | 261.14 ± 2.87d | 28.35 | 4.08 | 2.04 | 2.04 | 2.04 | 4.08 |
5 | 2.06 ± 0.23c | 195.41 ± 1.79e | 94.85 | 3.05 | 3.05 | 6.10 | 6.10 | 6.10 |
6 | 0.88 ± 0.12d | 277.62 ± 1.38f | 315.47 | 4.33 | 2.16 | 4.33 | 2.16 | 2.16 |
Paclitaxel | 0.57 ± 0.03e | 68.51 ± 0.19g | 120.19 | / | / | / | / | / |
/: not determined, SI = LC50 on Vero cells /MIC or LC50 on HeLa cells;
SI obtained from average MIC. Each LC50 value represents the mean ± SD (n = 3). In the same column, LC50 values marked with different superscript letters (a-g) are significantly different (p < 0.05).